Literature DB >> 3940435

A simple model relevant to toxoplasmosis applied to epidemiologic results in France.

L Papoz, F Simondon, W Saurin, H Sarmini.   

Abstract

A simple mathematical model was applied to the results of a seroepidemiologic study of toxoplasmosis carried out in France in 1982-1983. An adequate fitting to the prevalence data observed on 7,605 women of childbearing age was obtained. Thus, the data were used to estimate the seroconversion rate, allowing the approach to and discussion of insights gained from the model, such as the risk of Toxoplasma infection during pregnancy, the age-related expected risks of maternal seroconversion, as well as an overall prediction of the yearly number of congenitally infected infants in the total population. In addition, the high prevalence of congenital toxoplasmosis in France and the excess risk encountered by young migrant women from lower prevalence areas were confirmed by the model. The model might therefore be useful for public health purposes in other countries.

Entities:  

Mesh:

Year:  1986        PMID: 3940435     DOI: 10.1093/oxfordjournals.aje.a114210

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznań region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies.

Authors:  M Paul; E Petersen; J Szczapa
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection.

Authors:  A E Ades; C S Peckham; G E Dale; J M Best; S Jeansson
Journal:  J Epidemiol Community Health       Date:  1989-03       Impact factor: 3.710

3.  Detection of Toxoplasma gondii tachyzoites and bradyzoites in blood, urine, and brains of infected mice.

Authors:  T D Nguyen; M de Kesel; G Bigaignon; P Hoet; G Pazzaglia; M Lammens; M Delmee
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

4.  Longitudinal study of Toxoplasma seroprevalence in South Yorkshire.

Authors:  J Walker; D J Nokes; R Jennings
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

5.  Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia.

Authors:  B Bobić; I Jevremović; J Marinković; D Sibalić; O Djurković-Djaković
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

6.  Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants.

Authors:  Despina Contopoulos-Ioannidis; Kelsey M Wheeler; Raymund Ramirez; Cindy Press; Ernest Mui; Ying Zhou; Christine Van Tubbergen; Sheela Prasad; Yvonne Maldonado; Shawn Withers; Kenneth M Boyer; A Gwendolyn Noble; Peter Rabiah; Charles N Swisher; Peter Heydemann; Kristen Wroblewski; Theodore Karrison; Michael E Grigg; Jose G Montoya; Rima McLeod
Journal:  Clin Infect Dis       Date:  2015-09-24       Impact factor: 9.079

7.  Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.

Authors:  Eileen Stillwaggon; Christopher S Carrier; Mari Sautter; Rima McLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-27

8.  Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation.

Authors:  F Nogareda; Y Le Strat; I Villena; H De Valk; V Goulet
Journal:  Epidemiol Infect       Date:  2013-11-14       Impact factor: 4.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.